The University of Pennsylvania’s Abramson Cancer Center has been rated as “exceptional” by the National Cancer Institute (NCI) during a competitive research funding review by the government agency.

The Abramson Cancer Center, which is one of only 40 NCI-designated comprehensive cancer centers in the United States, received the prestigious honor following scientific review and evaluation of essential features of a cancer center, including the high quality of cancer research, state-of-the art research and patient care facilities, experienced scientific leadership, and the level of collaboration and translation of science to innovative cancer care.

Click here to view the full release.